A comprehensive review for gut microbes: technologies, interventions, metabolites and diseases. (8th February 2021)

• Record Type: Journal Article
• Authors: Qi, Changlu; Wang, Ping; Fu, Tongze; Lu, Minke; Cai, Yiting; Chen, Xu; Cheng, Liang
• Is Part Of: Briefings in functional genomics. Volume 20:Number 1(2021)
• Page Start: 42
• Page End: 60
• Publication Date: 2021-02-08
• Subjects: gut microbes -- metabolite -- intestinal epithelium -- immune system -- metabolic disease; Genomics -- Methodology -- Periodicals; Genomics -- Technological innovations -- Periodicals; 572.86072
• DOI: 10.1093/bfgp/elaa029
• Languages: English
• ISSNs: 2041-2649

Abstract

Abstract: Gut microbes have attracted much more attentions in the recent decade since their essential roles in the development of metabolic diseases, cancer and neurological diseases. Considerable evidence indicates that the metabolism of gut microbes exert influences on intestinal homeostasis and human diseases. Here, we first reviewed two mainstream sequencing technologies involving 16s rRNA sequencing and metagenomic sequencing for gut microbes, and data analysis methods assessing alpha and beta diversity. Next, we introduced some observational studies reflecting that many factors, such as lifestyle and intake of diets, drugs, contribute to gut microbes' quantity and diversity. Then, metabolites produced by gut microbes were presented to understand that gut microbes exert on host homeostasis in the intestinal epithelium and immune system. Finally, we focused on the molecular mechanism of gut microbes on the occurrence and development of several common diseases. In-depth knowledge of the relationship among interventions, gut microbes and diseases might provide new insights in to disease prevention and treatment.